MyFinsight
Home
Blog
About
Contact
Download
Download image
Net decrease in cash
and cash...
-$3,351,416
Accrued expenses
$310,857
Depreciation and
amortization
$114,518
Accounts payable
$74,310
Prepaid expenses and
other assets
-$40,002
Operating lease
right-of-use asset
-$28,221
Stock-based compensation
expense
$14,340
Net cash used in
operating activities
-$3,227,240
Net cash (used)
provided by financing...
-$118,513
Net cash used in
investing activities
-$5,663
Canceled cashflow
$582,248
Net loss
-$3,630,610
Principal repayments on
finance leases
$77,174
Payment on loans payable
$29,544
something is missing
-$11,795
Purchase of property and
equipment
$5,663
Accounts and other
receivables
$143,274
Inventory
$24,339
Unearned revenue
-$11,265
Back
Back
Cash Flow
bioAffinity Technologies, Inc. (BIAF)
bioAffinity Technologies, Inc. (BIAF)
source: myfinsight.com